GLENMARK PHARMACEUTICALS LTD. - Announcement under Regulation 30 (LODR)-Press Release / Media Release

11 Nov 2020

Glenmark Pharmaceuticals receives ANDA approval for Tacrolimus Capsules USP, 0.5 mg, 1 mg and 5 mg

Source: BSE India

View all announcements for GLENMARK PHARMACEUTICALS LTD.